Seeking a unique lipid signature predicting cardiovascular disease risk

Circulation

Volumn 129, Issue 18, 2014, Pages 1799-1803

  Brown, J Mark ^a   Hazen, Stanley L ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

Author keywords

atherosclerosis; cholesterol; Editorials; lipids; triglycerides

Indexed keywords

ALBUMIN; AMIDE; APOLIPOPROTEIN B; BIOLOGICAL MARKER; CARBON; CHOLESTEROL; CHOLESTEROL ESTER; CHOLINE; ETHANOLAMINE; FATTY ACID; GLYCEROL; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LIPID; LIPIDOME; LIPOPROTEIN; LYSOPHOSPHATIDYLCHOLINE; PALMITOLEIC ACID; PHOSPHATIDYLCHOLINE; PHOSPHATIDYLCHOLINE STEROL ACYLTRANSFERASE; PHOSPHATIDYLETHANOLAMINE; PHOSPHATIDYLSERINE; PHOSPHOLIPID; PLASMALOGEN; POLYUNSATURATED FATTY ACID; SERINE; SPHINGOLIPID; SPHINGOMYELIN; TOLL LIKE RECEPTOR 4; TRIACYLGLYCEROL; VERY LOW DENSITY LIPOPROTEIN;

ADIPOSE TISSUE; ALZHEIMER DISEASE; ATHEROSCLEROSIS; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CHRONIC DISEASE; DIABETES MELLITUS; DISEASE ASSOCIATION; DISEASE COURSE; FRAMINGHAM RISK SCORE; GENE DELETION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HYPERCHOLESTEROLEMIA; HYPERTENSION; INFECTION; LIPID PEROXIDATION; LIPIDOMICS; LIPOGENESIS; MASS SPECTROMETRY; MEDITERRANEAN DIET; MOLECULE; NEOPLASM; NONHUMAN; OBESITY; PATHOGENESIS; PATHOLOGY; PRIORITY JOURNAL; REVIEW; VASCULITIS;

ATHEROSCLEROSIS; CHOLESTEROL; EDITORIALS; LIPIDS; TRIGLYCERIDES;

CARDIOVASCULAR DISEASES; FEMALE; HUMANS; LIPIDOSES; MALE; METABOLOMICS;

EID: 84900478217     PISSN: 00097322     EISSN: 15244539     Source Type: Journal    
DOI: 10.1161/CIRCULATIONAHA.114.009224     Document Type: Review

References (20)

1. Steinberg D. Thematic review series: the pathogenesis of atherosclerosis: an interpretive history of the cholesterol controversy, part I. J Lipid Res. 2004;45:1583-1593.
2. Witztum JL, Berliner JA. Oxidized phospholipids and isoprostanes in atherosclerosis. Curr Opin Lipidol. 1998;9:441-448.
3. Zethelius B, Berglund L, Sundstrom J, Ingelsson E, Basu S, Larsson A, Venge P, Arnlöv J. Use of multiple biomarkers to improve prediction of death from myocardial infarction. N Engl J Med. 2008;358:2107-2016.
4. Atilla-Gokcumen GE, Muro E, Relat-Goberna J, Sasse S, Bedigian A, Coughlin ML, Garcia-Manyes S, Eggert US. Dividing cells regulate their lipid composition and localization. Cell. 2014;156:428-439.
5. Weir JM, Wong G, Barlow CK, Greeve MA, Kowalczyk A, Almasy L, Comuzzie AG, Mahaney MC, Jowett JB, Shaw J, Curran JE, Blangero J, Meikle PJ. Plasma lipid profling in a large population-based cohort. J Lipid Res. 2013;54:2898-2908.
6. Kien CL, Bunn JY, Poynter ME, Stevens R, Bain J, Ikayeva O, Fukagawa NK, Champagne CM, Crain KI, Koves TR, Muoio DM. A lipidomics analysis of the relationship between dietary fatty acid composition and insulin sensitivity in young adults. Diabetes. 2013;62:1054-1063.
7. Kulkarni H, Meikle PJ, Mamtani M, Weir JM, Barlow CK, Jowett JB, Bellis C, Dyer TD, Johnson MP, Rainwater DL, Almasy L, Mahaney MC, Comuzzie AG, Blangero J, Curran JE. Plasma lipidomic profle signature of hypertension in Mexican American families: specifc role of diacylglyc-erols. Hypertension. 2013;62:621-626.
8. Sanchez-Mejia RO, Newman JW, Toh S, Yu GQ, Zhou Y, Halabisky B, Cissé M, Scearce-Levie K, Cheng IH, Gan L, Palop JJ, Bonventre JV, Mucke L. Phospholipase A2 reduction ameliorates cognitive defcits in a mouse model of Alzheimer's disease. Nat Neurosci. 2008;11:1311-1318.
9. Morita M, Kuba K, Ichikawa A, Nakayama M, Katahira J, Iwamoto R, Watanebe T, Sakabe S, Daidoji T, Nakamura S, Kadowaki A, Ohto T, Nakanishi H, Taguchi R, Nakaya T, Murakami M, Yoneda Y, Arai H, Kawaoka Y, Penninger JM, Arita M, Imai Y. The lipid mediator protec-tin D1 inhibits infuenza virus replication and improves severe infuenza. Cell. 2013;153:112-125.
10. Puri R, Duong M, Uno K, Kataoka Y, Nicholls SJ. The emerging role of plasma lipidomics in cardiovascular drug discovery. Expert Opin Drug Discov. 2012;7:63-72.
11. Stegemann C, Pechlaner R, Willeit P, Langley SR, Mangino M, Mayr U, Menni C, Moayyeri A, Santer P, Rungger G, Spector TD, Willeit J, Kiechl S, Mayr M. Lipidomics profling and risk of cardiovascular disease in the prospective population-based Bruneck Study. Circulation 2014;129:1821-1831.
12. Kishimoto K, Urade R, Ogawa T, Moriyama T. Nondestructive quantifca-tion of neutral lipids by thin-layer chromatography and laser-fuorescent scanning: suitable methods for "lipidome" analysis. Biochem Biophys Res Commun. 2001;281:657-662.
13. Baum SJ, Kris-Etherton PM, Willett WC, Lichtenstein AH, Rudel LL, Maki KC, Whelan J, Ramsden CE, Block RC. Fatty acids in cardiovascular health and disease: a comprehensive update. J Clin Lipidol. 2012;6:216-234.
14. Malmros H, Wigand G. The effect on serum-cholesterol of diets containing different fats. Lancet. 1957;273:1-7.
15. Fessler MB, Rudel LL, Brown JM. Toll-like receptor signaling links dietary fatty acids to the metabolic syndrome. Curr Opin Lipidol. 2009;20:379-385.
16. Melchior JT, Sawyer JK, Kelley KL, Shah R, Wilson MD, Hantgan RR, Rudel LL. LDL particle core enrichment in cholesteryl oleate increases proteoglycan binding and promotes atherosclerosis. J Lipid Res. 2013;54:2495-2503.
17. Brown JM, Shelness GS, Rudel LL. Monounsaturated fatty acids and atherosclerosis: opposing views from epidemiology and experimental animal models. Curr Atheroscler Rep. 2007;9:494-500.
18. Rudel LL, Lee RG, Parini P. ACAT2 is a target for treatment of coronary heart disease associated with hypercholesterolemia. Arterioscler Thromb Vasc Biol. 2005;25:1112-1118.
19. Chandak PG, Obrowsky S, Radovic B, Doddapattar P, Afaki E, Kratzer A, Doshi LS, Povoden S, Ahammer H, Hoefer G, Levak-Frank S, Kratky D. Lack of acyl-CoA:diacylglycerol acyltransferase 1 reduces intestinal cholesterol absorption and attenuates atherosclerosis in apolipoprotein E knockout mice. Biochim Biophys Acta. 2011;1811:1011-1020.
20. Willner EL, Tow B, Buhman KK, Wilson M, Sanan DA, Rudel LL, Farese RV Jr. Defciency of acyl CoA:cholesterol acyltransferase 2 prevents atherosclerosis in apolipoprotein E-defcient mice. Proc Natl Acad Sci U S A. 2003;100:1262-1267.